Vasar V - Search Results

1

Peripheral gene expression profiling of CCK-4-induced panic in healthy subjects.

Maron E, Kallassalu K, Tammiste A, Kolde R, Vilo J, Tõru I, Vasar V, Shlik J, Metspalu A. Maron E, et al. Among authors: vasar v. Am J Med Genet B Neuropsychiatr Genet. 2010 Jan 5;153B(1):269-74. doi: 10.1002/ajmg.b.30898. Am J Med Genet B Neuropsychiatr Genet. 2010. PMID: 19051287

2

Association testing of panic disorder candidate genes using CCK-4 challenge in healthy volunteers.

Maron E, Tõru I, Tasa G, Must A, Toover E, Lang A, Vasar V, Shlik J. Maron E, et al. Among authors: vasar v. Neurosci Lett. 2008 Dec 3;446(2-3):88-92. doi: 10.1016/j.neulet.2008.09.052. Neurosci Lett. 2008. PMID: 18832011

3

Interleukin 10 family gene polymorphisms are not associated with major depressive disorder and panic disorder phenotypes.

Koido K, Eller T, Kingo K, Kõks S, Traks T, Shlik J, Vasar V, Vasar E, Maron E. Koido K, et al. Among authors: vasar v, vasar e. J Psychiatr Res. 2010 Apr;44(5):275-7. doi: 10.1016/j.jpsychires.2009.09.001. Epub 2009 Sep 27. J Psychiatr Res. 2010. PMID: 19786281

4

Associations between personality traits and CCK-4-induced panic attacks in healthy volunteers.

Tõru I, Aluoja A, Võhma U, Raag M, Vasar V, Maron E, Shlik J. Tõru I, et al. Among authors: vasar v. Psychiatry Res. 2010 Jul 30;178(2):342-7. doi: 10.1016/j.psychres.2010.04.003. Epub 2010 May 14. Psychiatry Res. 2010. PMID: 20471107

5

The effect of 6-week treatment with escitalopram on CCK-4 challenge: a placebo-controlled study in CCK-4-sensitive healthy volunteers.

Tõru I, Maron E, Raag M, Vasar V, Nutt DJ, Shlik J. Tõru I, et al. Among authors: vasar v. Eur Neuropsychopharmacol. 2013 Jul;23(7):645-52. doi: 10.1016/j.euroneuro.2012.08.011. Epub 2012 Aug 29. Eur Neuropsychopharmacol. 2013. PMID: 22939006 Clinical Trial.

6

Tryptophan depletion does not modify response to CCK-4 challenge in patients with panic disorder after treatment with citalopram.

Tõru I, Shlik J, Maron E, Vasar V, Nutt DJ. Tõru I, et al. Among authors: vasar v. Psychopharmacology (Berl). 2006 May;186(1):107-12. doi: 10.1007/s00213-006-0351-1. Epub 2006 Mar 16. Psychopharmacology (Berl). 2006. PMID: 16541242 Clinical Trial.

7

Association study of tryptophan hydroxylase 2 gene polymorphisms in panic disorder.

Maron E, Tõru I, Must A, Tasa G, Toover E, Vasar V, Lang A, Shlik J. Maron E, et al. Among authors: vasar v. Neurosci Lett. 2007 Jan 16;411(3):180-4. doi: 10.1016/j.neulet.2006.09.060. Epub 2006 Nov 22. Neurosci Lett. 2007. PMID: 17123728

8

The effect of 5-hydroxytryptophan on cholecystokinin-4-induced panic attacks in healthy volunteers.

Maron E, Tõru I, Vasar V, Shlik J. Maron E, et al. Among authors: vasar v. J Psychopharmacol. 2004 Jun;18(2):194-9. doi: 10.1177/0269881104042619. J Psychopharmacol. 2004. PMID: 15260907 Clinical Trial.

9

Association between serotonin-related genetic polymorphisms and CCK-4-induced panic attacks with or without 5-hydroxytryptophan pretreatment in healthy volunteers.

Maron E, Tasa G, Tõru I, Lang A, Vasar V, Shlik J. Maron E, et al. Among authors: vasar v. World J Biol Psychiatry. 2004 Jul;5(3):149-54. doi: 10.1080/15622970410029927. World J Biol Psychiatry. 2004. PMID: 15346539

10

Associations between serotonin-related gene polymorphisms and panic disorder.

Maron E, Lang A, Tasa G, Liivlaid L, Tõru I, Must A, Vasar V, Shlik J. Maron E, et al. Among authors: vasar v. Int J Neuropsychopharmacol. 2005 Jun;8(2):261-6. doi: 10.1017/S1461145704004985. Epub 2005 Jan 26. Int J Neuropsychopharmacol. 2005. PMID: 15670397 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters